Post sponsored by

Source: United States House of Representatives – Congressman Marc Veasey (33rd District of Texas)

Headline: Veasey-Led Bills to Address the Opioid Epidemic Pass U.S. House of Representatives

Nov 18, 2020

Press Release

WASHINGTON, D.C. – Last night, the U.S. House of Representatives passed two Veasey-led bills to curb the nation’s opioid epidemic. The Fairness in Orphan Drug Exclusivity Act closes a loophole that blocks pharmaceutical competition and prevents innovative treatments for opioid use disorder from coming to market and the State Opioid Response Grant Authorization Act provides nine billion dollars in funding over six years for state and tribal governments to implement prevention, treatment, and recovery for opioid use disorders, including through the use of medication-assisted treatment.  

“America’s opioid epidemic does not discriminate—every year this public health crisis impacts millions of families in every crevice of our country,” said Congressman Veasey. “These pieces of legislation will offer bold, united solutions that will help expand treatment options and lower medication-assisted treatments to curb the senseless loss of life. I want to thank my colleagues on both the Energy and Commerce and Committee and the full House of Representatives for understanding the urgency of the opioid and addiction crisis in America.”

The passage of these bills builds on Congressman Veasey’s robust record to expand affordable and accessible healthcare during the 116th Congress. Just in this Congress, Congressman Veasey had joined his colleagues to lower prescription drugs costs, protect those with pre-existing conditions,  bolster the Affordable Care Act, expand Medicaid in states like Texas with high uninsured population, and advance legislation that will curb the COVID-19 health pandemic.

To read a summary of the Fairness in Orphan Drug Exclusivity Act, click here.

To read a summary of the State Opioid Response Grant Authorization Act, click here.